Asher N, Bar-Hai N, Ben-Betzalel G, Stoff R, et al. Exploring the clinical significance of specific immune-related adverse events in melanoma patients undergoing immune checkpoint inhibitor therapy. Melanoma Res 2024 Jun 24. doi: 10.1097/CMR.0000000000000985.
PMID: 38913412